Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADHD NOS”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT00181766
What this trial is testing

Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)

Who this might be right for
ADHD NOS
Massachusetts General Hospital 45
Not applicableUnknownNCT02572180
What this trial is testing

A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention-deficit Hyperactivity Disorder of Childhood or Adolescence Nos
University Hospital Tuebingen 90
Post-approval studies (Phase 4)Study completedNCT01238575
What this trial is testing

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Who this might be right for
Pervasive Development Disorders
Yale University 62
Not applicableLooking for participantsNCT06978452
What this trial is testing

Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories

Who this might be right for
Depression - Major Depressive DisorderBipolarPsychosis+4 more
Douglas Mental Health University Institute 560
Not applicableStudy completedNCT03260725
What this trial is testing

Evaluating the Feasibility of Internet-delivered PCIT

Who this might be right for
Oppositional Defiant DisorderConduct DisorderDisruptive Behavior Disorder Nos
Florida International University 40
Not applicableStudy completedNCT00916071
What this trial is testing

Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders

Who this might be right for
Bulimia NervosaEating DisordersADHD
Massachusetts General Hospital 64
Post-approval studies (Phase 4)Study completedNCT00181740
What this trial is testing

Concerta Treatment in Adults With ADHD NOS

Who this might be right for
ADHD NOS
Massachusetts General Hospital 30
Post-approval studies (Phase 4)Study completedNCT00844753
What this trial is testing

Atomoxetine, Placebo and Parent Management Training in Autism

Who this might be right for
AutismPervasive Development DisorderAsperger's Disorder+1 more
University of Rochester 128
Not applicableStudy completedNCT00181857
What this trial is testing

Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)

Who this might be right for
ADHD
Massachusetts General Hospital 58
Post-approval studies (Phase 4)Study completedNCT00586573
What this trial is testing

Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

Who this might be right for
ADHD
Massachusetts General Hospital 34
Large-scale testing (Phase 3)Study completedNCT00266552
What this trial is testing

The Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation

Who this might be right for
Conduct DisorderDisruptive Behavior DisorderOppositional Defiant Disorder
Janssen Pharmaceutica N.V., Belgium 118
Large-scale testing (Phase 3)Study completedNCT00250354
What this trial is testing

The Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

Who this might be right for
Conduct DisorderOppositional Defiant DisorderDisruptive Behavior Disorder
Janssen Pharmaceutica N.V., Belgium 110